ALXN2230

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ALXN2230, covering 2026-04-09 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN2230 in Healthy Participants [Phase 1]